|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.90 EUR | -2.10% |
|
-2.91% | +42.83% |
| 07-31 | Mizuho Trims Price Target on Axsome Therapeutics to $306 From $310, Keeps Outperform Rating | MT |
| 07-21 | BMO Capital Initiates Axsome Therapeutics at Outperform With $310 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.59% | +2.85% | +17.43% | +9.72% | +1.62% | +39.32% | -0.16% | +27.76% | +87.09% | 78.32B | |
| +2.77% | +4.78% | +17.43% | +5.71% | -8.20% | -0.98% | +26.82% | +11.33% | - | 51.1B | |
| +1.17% | +1.94% | -4.81% | -4.28% | -5.41% | +20.95% | +177.27% | +136.14% | +233.68% | 49.18B | |
| +1.72% | +8.18% | +9.42% | +33.47% | -22.11% | -49.03% | -49.18% | -54.44% | +16.49% | 44.71B | |
| +0.80% | +2.46% | +4.54% | +7.49% | +18.15% | +59.13% | -23.35% | -38.88% | -33.87% | 30.72B | |
| +1.84% | +0.87% | +1.72% | +22.32% | +22.06% | +53.80% | +84.29% | +60.08% | +39.41% | 24.44B | |
| +9.86% | +7.94% | -22.71% | +8.87% | +100.64% | +126.53% | -41.89% | -87.79% | - | 23.62B | |
| +2.58% | +13.14% | +8.47% | +10.25% | +27.61% | +8.17% | +202.17% | +27.36% | - | 21.05B | |
| +0.18% | +4.04% | -3.74% | +2.16% | +36.30% | +66.15% | +116.21% | +159.20% | +341.67% | 16.61B | |
| +2.03% | +5.48% | -6.31% | +25.36% | +10.45% | +81.37% | +166.75% | +58.23% | - | 16.51B | |
| +3.92% | +28.53% | +32.17% | +16.45% | -11.79% | -7.79% | +735.62% | +440.07% | +5,974.04% | 15.07B | |
| +3.82% | +6.31% | +6.40% | +18.04% | +7.37% | +11.30% | -31.56% | -17.66% | -32.94% | 12.35B | |
| +1.24% | -2.41% | -14.55% | -2.13% | +16.48% | +103.00% | +203.61% | +677.27% | +2,695.53% | 10.95B | |
| +1.17% | -4.30% | -12.06% | +6.78% | +32.41% | +135.43% | +175.44% | +439.85% | - | 9.66B | |
| +6.04% | +26.35% | +23.49% | +103.47% | +264.66% | +351.13% | +411.81% | +2.51% | - | 7.25B | |
| -1.23% | -0.15% | +12.81% | +13.76% | -6.12% | -20.34% | -24.22% | -51.87% | -48.45% | 7.05B | |
| +9.98% | +15.07% | -8.09% | -5.12% | +14.28% | +37.31% | +254.76% | +231.44% | - | 6.24B | |
| +2.18% | +1.40% | +11.08% | +15.88% | +2.38% | +13.35% | +68.17% | -9.42% | - | 6.15B | |
| -0.59% | +2.31% | +16.34% | +29.80% | +84.39% | +136.58% | +335.13% | +487.34% | - | 5.93B | |
| Average | +2.69% | +6.18% | +4.69% | +16.74% | +30.80% | +61.34% | +146.72% | +131.50% | +927.27% | 23B | |
| Weighted average by Cap. | +2.36% | +5.21% | +6.32% | +12.81% | +14.13% | +37.97% | +88.35% | +71.87% | +495.61% |
- Stock Market
- Stocks
- AXSM Stock
- 19X Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
